Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Westermark

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Clinical and Experimental Immunology|August 1, 1988
Immunohistochemical identification of heparan sulphate proteoglycan in secondary systemic amyloidosisB Norling, G T Westermark, P Westermark
Pancreas|September 7, 2000
Amyloid in human islets of Langerhans: immunologic evidence that islet amyloid polypeptide is modified in amyloidogenesisZ Ma, P Westermark, G T Westermark
Plos One|July 8, 2009
Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal modelPer Westermark, Katarzyna Lundmark, Gunilla T Westermark
Scandinavian Journal of Immunology|November 1, 1989
Massive vascular AA-amyloidosis: a histologically and biochemically distinctive subtype of reactive systemic amyloidosisG T Westermark, K Sletten, P Westermark
Biochemical and Biophysical Research Communications|January 15, 1992
The N-terminal segment of protein AA determines its fibrillogenic propertyG T Westermark, U Engström, P Westermark
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2018
Development of Mouse Monoclonal Antibodies Against Human Amyloid Fibril Proteins for Diagnostic and Research PurposesGunilla T Westermark, Elisabet Ihse, Per Westermark
Clinical and Experimental Immunology|October 1, 1991
Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosisG T Westermark, B Norling, P Westermark
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1987
Amyloid fibril protein AA. Characterization of uncommon subspecies from a patient with rheumatoid arthritisG T Westermark, P Westermark, K Sletten
Plos One|November 16, 2013
Depletion of spleen macrophages delays AA amyloid development: a study performed in the rapid mouse model of AA amyloidosisKatarzyna Lundmark, Aida Vahdat Shariatpanahi, Gunilla T Westermark
Plos One|October 3, 2008
AA-amyloidosis can be transferred by peripheral blood monocytesJana Sponarova, Sofia N Nyström, Gunilla T Westermark
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Clinical and Experimental Immunology|August 1, 1988
Immunohistochemical identification of heparan sulphate proteoglycan in secondary systemic amyloidosisB Norling, G T Westermark, P Westermark
Pancreas|September 7, 2000
Amyloid in human islets of Langerhans: immunologic evidence that islet amyloid polypeptide is modified in amyloidogenesisZ Ma, P Westermark, G T Westermark
Plos One|July 8, 2009
Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal modelPer Westermark, Katarzyna Lundmark, Gunilla T Westermark
Scandinavian Journal of Immunology|November 1, 1989
Massive vascular AA-amyloidosis: a histologically and biochemically distinctive subtype of reactive systemic amyloidosisG T Westermark, K Sletten, P Westermark
Biochemical and Biophysical Research Communications|January 15, 1992
The N-terminal segment of protein AA determines its fibrillogenic propertyG T Westermark, U Engström, P Westermark
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2018
Development of Mouse Monoclonal Antibodies Against Human Amyloid Fibril Proteins for Diagnostic and Research PurposesGunilla T Westermark, Elisabet Ihse, Per Westermark
Clinical and Experimental Immunology|October 1, 1991
Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosisG T Westermark, B Norling, P Westermark
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1987
Amyloid fibril protein AA. Characterization of uncommon subspecies from a patient with rheumatoid arthritisG T Westermark, P Westermark, K Sletten
Plos One|November 16, 2013
Depletion of spleen macrophages delays AA amyloid development: a study performed in the rapid mouse model of AA amyloidosisKatarzyna Lundmark, Aida Vahdat Shariatpanahi, Gunilla T Westermark
Plos One|October 3, 2008
AA-amyloidosis can be transferred by peripheral blood monocytesJana Sponarova, Sofia N Nyström, Gunilla T Westermark
Pageof 13